PIK3CA and cancer: The cancer pathways affected included MAP kinase, cell cycle, actin cytoskeleton regulation, and PI3K-Akt signaling [39], and mutations in ATG2A, WEE1, DST, and TSC2 were identified for the first time in OSCCs [17].